Anti-apoptotic proteins like Bcl-2 and Bcl-xL play a significant role in cell death inhibition. These proteins bind to and inhibit pro-apoptotic proteins, preventing the initiation of the apoptotic cascade. Overexpression of these proteins is commonly observed in various cancers and is associated with resistance to therapy. Targeting these proteins with specific inhibitors is an area of active research in cancer therapy.
